Publication Name	World Journal of Meta-Analysis
Manuscript ID	91264
Country	United States

Received	2023-12-29 06:40
Peer-Review Started	2023-12-29 06:40
To Make the First Decision
Return for Revision	2024-04-08 07:09
Revised	2024-04-18 06:16
Second Decision	2024-06-07 02:47
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-06-07 09:39
Articles in Press	2024-06-07 09:39
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-06-14 01:03
Publish the Manuscript Online	2024-06-14 06:24

ISSN	2308-3840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, General & Internal
Manuscript Type	Minireviews
Article Title	Development of donor specific antibodies after SARS-CoV-2 vaccination: What do we know so far?
Manuscript Source	Invited Manuscript
All Author List	Ahmed Daoud, Karim Soliman, Maria Aurora Posadas Salas, Sakshi Vaishnav, Genta Uehara, Ahmed Abdelkader, Tibor Fulop and Michael J Casey
Funding Agency and Grant Number
Corresponding Author	Ahmed Daoud, MD, PhD, Doctor, Doctor, Staff Physician, Department of Medicine, Division of Nephrology, Medical University of South Carolina, 96 Jonathan Lucas street, Charleston, SC 29425, United States. ahmed.daoud84@yahoo.com
Key Words	COVID-19; SARS-CoV-2 vaccination; Kidney; Renal transplant; Donor specific antibodies
Core Tip	Our aim was to find out whether vaccines against Coronavirus disease 2019 (COVID-19) lead to an immunological response stimulating the production of de novo donor specific antibodies (DSAs) or increase in mean fluorescence intensity of pre-existing DSAs in kidney transplant recipients. We did a detailed literature search through December 2, 2023 using PubMed as the primary database. We used the following keywords: COVID-19, severe acute respiratory syndrome-coronavirus-2 vaccination, Kidney, Renal transplant, and DSAs. The results from related studies were collated and analyzed.
Publish Date	2024-06-14 06:24
Citation	<p>Daoud A, Soliman K, Posadas Salas MA, Vaishnav S, Uehara G, Abdelkader A, Fulop T, Casey MJ. Development of donor specific antibodies after SARS-CoV-2 vaccination: What do we know so far? <i>World J Meta-Anal</i> 2024; 12(2): 91264</p>
URL	https://www.wjgnet.com/2308-3840/full/v12/i2/91264.htm
DOI	https://dx.doi.org/10.13105/wjma.v12.i2.91264

Full Article (PDF)	WJMA-12-91264-with-cover.pdf
Manuscript File	91264_Auto_Edited-JLW.docx
Answering Reviewers	91264-answering-reviewers.pdf
Audio Core Tip	91264-audio.m4a
Conflict-of-Interest Disclosure Form	91264-conflict-of-interest-statement.pdf
Copyright License Agreement	91264-copyright-assignment.pdf
Peer-review Report	91264-peer-reviews.pdf
Scientific Misconduct Check	91264-scientific-misconduct-check.png
Scientific Editor Work List	91264-scientific-editor-work-list.pdf
CrossCheck Report	91264-crosscheck-report.pdf